Results 1 to 10 of about 111,232 (150)

Attitudes and perceptions about the use of long-acting injectable antipsychotics among behavioral health practitioners [PDF]

open access: yesMental Health Clinician, 2023
Introduction: Long-acting injectable antipsychotics (LAI-As) are important tools for the treatment of schizophrenia, yet they appear to be underutilized.
Shaina Schwartz, PharmD, BCPP   +4 more
doaj   +1 more source

Comparison of inpatient psychiatric medication management in gender diverse youth with cisgender peers [PDF]

open access: yesMental Health Clinician, 2023
Introduction The primary objective was to determine if gender diverse (GD) youth receive different psychotropic prescribing compared with cisgender (CG) peers with the same diagnosis.
Carrillo Nina PharmD   +3 more
doaj   +1 more source

Quetiapine and olanzapine misuse prevalence in a US general population sample [PDF]

open access: yesMental Health Clinician, 2023
Introduction: Second-generation antipsychotics (SGA) are associated with misuse potential; however, there are limited data describing the prevalence and characteristics of this misuse.
Kirk E Evoy, PharmD, BCACP, BC-ADM, CTTS   +4 more
doaj   +1 more source

Effects of Risperidone and Prenatal Poly I:C Exposure on GABAA Receptors and AKT-GSK3β Pathway in the Ventral Tegmental Area of Female Juvenile Rats

open access: yesBiomolecules, 2022
The ventral tegmental area (VTA) in the ventral midbrain is the origin of the dopaminergic neurotransmission pathways. Although GABAA receptors and AKT-GSK3β signaling are involved in the pathophysiology of mental disorders and are modulated by ...
Shiyan Chen   +3 more
doaj   +1 more source

Epigenetic histone acetylation modulating prenatal Poly I:C induced neuroinflammation in the prefrontal cortex of rats: a study in a maternal immune activation model

open access: yesFrontiers in Cellular Neuroscience, 2022
Introduction: Neuroinflammation in the central nervous system, particularly the prefrontal cortex (PFC), plays a role in the pathogenesis of schizophrenia, which has been found to be associated with maternal immune activation (MIA).
Yueqing Su   +9 more
doaj   +1 more source

Receptors Involved in Mental Disorders and the Use of Clozapine, Chlorpromazine, Olanzapine, and Aripiprazole to Treat Mental Disorders

open access: yesPharmaceuticals, 2023
Mental illnesses are a global health challenge, and effective medicines are needed to treat these conditions. Psychotropic drugs are commonly prescribed to manage mental disorders, such as schizophrenia, but unfortunately, they can cause significant and ...
Ronald Mlambo   +4 more
doaj   +1 more source

Late onset psychosis treatment with adjunctive medicines

open access: yesFrontiers in Psychiatry, 2023
BackgroundA number of studies have shown the feasibility of using adjunctive drugs in late onset psychosis (LOP).AimTesting hypothesis that among LOP people treated with antipsychotics and antidepressants, basing on certain clinical characteristics a ...
Irina Boksha   +6 more
doaj   +1 more source

Cross-sectional study on the dissociation of decision-making capacity for antipsychotic treatment and COVID-19 vaccination in individuals with schizophrenia

open access: yesFrontiers in Psychiatry, 2023
ObjectiveDecision-making capacity for treatment is impaired in schizophrenia but it remains unknown if schizophrenia affects distinct decision-making capacities differently.MethodsIn this study, we assessed concomitantly two decision-making capacities (i.
Stéphane Raffard   +9 more
doaj   +1 more source

Assessment of the Risk of Antipsychotics in Patients with Dementia in Actual Clinical Practice in Primary Health Care

open access: yesPharmaceuticals, 2021
Behavioral and psychological symptoms are almost universal in elderly patients with dementia. Antipsychotic drugs can be used but only in specific contexts as they can generate severe adverse effects. The main aim of this research was to evaluate the use
María del Carmen González-López   +3 more
doaj   +1 more source

Ingestible Sensors and Medication Adherence: Focus on Use in Serious Mental Illness

open access: yesPharmacy, 2020
Background: Poor medication adherence is a major public health concern. Patients living with a serious mental illness (SMI) commonly present with non-adherence to their medication regimen, which can lead to relapse and hospitalizations. The high rates of
Azita Alipour   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy